Beta receptor blocking and antiarrhythmic properties of tolamolol.
D000200:Action Potentials / Q000187:drug effects; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001549:Benzamides / Q000008:administration & dosage / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002036:Bundle of His / Q000187:drug effects; D003408:Cresols / Q000008:administration & dosage / Q000494:pharmacology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D006339:Heart Rate / Q000187:drug effects; D006892:Hydroxydopamines / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D010042:Ouabain / Q000037:antagonists & inhibitors; D010525:Peripheral Nerves / Q000098:blood supply; D011412:Propanolamines / Q000008:administration & dosage / Q000494:pharmacology*; D011690:Purkinje Fibers / Q000187:drug effects; D012039:Regional Blood Flow / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D001549:Benzamides; D003408:Cresols; D006892:Hydroxydopamines; D011412:Propanolamines; D010042:Ouabain; D007545:Isoproterenol